GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (CHIX:IDHCl) » Definitions » 12-1 Month Momentum %

Integrated Diagnostics Holdings (CHIX:IDHCL) 12-1 Month Momentum % : 28.06% (As of Dec. 15, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Integrated Diagnostics Holdings 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-15), Integrated Diagnostics Holdings's 12-1 Month Momentum % is 28.06%.

The industry rank for Integrated Diagnostics Holdings's 12-1 Month Momentum % or its related term are showing as below:

CHIX:IDHCl's 12-1 Month Momentum % is ranked better than
78.95% of 228 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.455 vs CHIX:IDHCl: 28.06

Competitive Comparison of Integrated Diagnostics Holdings's 12-1 Month Momentum %

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's 12-1 Month Momentum % falls into.



Integrated Diagnostics Holdings  (CHIX:IDHCl) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Integrated Diagnostics Holdings  (CHIX:IDHCl) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Integrated Diagnostics Holdings 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings Business Description

Traded in Other Exchanges
Address
IFC 5, Saint Helier, JEY, JE1 1ST
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria; and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, Contract Segment which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings Headlines

No Headlines